Intrinsic Value of S&P & Nasdaq Contact Us

Bellerophon Therapeutics, Inc. BLPH NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
37/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — BLPH

Bellerophon Therapeutics, Inc. (BLPH) has a market capitalization of $146.79K and trades at $0.01. The 52-week range is 0.01-0.1.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-2.08.

The stock has a beta of 0.70, a last dividend of $0.0190, operates in the Healthcare sector.

Trading Data
Current Price$0.01
52-Week Range0.01-0.1
Volume1.57K
Avg Volume (30D)13.69K
Market Cap$146.79K
Beta (1Y)0.70
Last Dividend$0.0190
Company
IPO Date2015-02-13
Employees18
CEOCraig R. Jalbert CIRA
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS0787713009
CUSIP078771300
Income (Latest Year)
Gross Profit$-65K
EBITDA$-22.18M
Operating Income$-22.38M
Net Income$-19.83M
EPS$-2.08
EPS Diluted$-2.08
Shares Outstanding$9.55M
Balance Sheet (Latest Year)
Total Assets$7.94M
Current Assets$7.56M
Cash & ST Investments$7.33M
Total Liabilities$5.4M
Total Debt$203K
Net Debt$-6.72M
Total Equity$2.53M
Debt / Equity0.08
Valuation Ratios
P/E Ratio-0
P/B Ratio0.06
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message